Jiedong Zhou

686 total citations
28 papers, 462 citations indexed

About

Jiedong Zhou is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Jiedong Zhou has authored 28 papers receiving a total of 462 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cardiology and Cardiovascular Medicine, 10 papers in Molecular Biology and 7 papers in Surgery. Recurrent topics in Jiedong Zhou's work include Chemotherapy-induced cardiotoxicity and mitigation (7 papers), Cardiovascular, Neuropeptides, and Oxidative Stress Research (3 papers) and Ferroptosis and cancer prognosis (3 papers). Jiedong Zhou is often cited by papers focused on Chemotherapy-induced cardiotoxicity and mitigation (7 papers), Cardiovascular, Neuropeptides, and Oxidative Stress Research (3 papers) and Ferroptosis and cancer prognosis (3 papers). Jiedong Zhou collaborates with scholars based in China, Japan and Israel. Jiedong Zhou's co-authors include Hai Tian, Jinquan Wang, Atsushi Fukunaga, Junji Yodoi, Shujing Li, Jufang Chi, Hangyuan Guo, Hui Lin, Juntao Yang and Peipei Zhang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Jiedong Zhou

26 papers receiving 458 citations

Peers

Jiedong Zhou
Jiedong Zhou
Citations per year, relative to Jiedong Zhou Jiedong Zhou (= 1×) peers Zhihui Zhang

Countries citing papers authored by Jiedong Zhou

Since Specialization
Citations

This map shows the geographic impact of Jiedong Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiedong Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiedong Zhou more than expected).

Fields of papers citing papers by Jiedong Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiedong Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiedong Zhou. The network helps show where Jiedong Zhou may publish in the future.

Co-authorship network of co-authors of Jiedong Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Jiedong Zhou. A scholar is included among the top collaborators of Jiedong Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiedong Zhou. Jiedong Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Jiedong, et al.. (2025). Immunometabolism and male reproductive function: linking inflammation, oxidative stress, and declining fertility. Frontiers in Immunology. 16. 1736492–1736492.
2.
Zhou, Jinhui, Jiale Liu, Yaxuan Wang, et al.. (2025). TXM-CB13 Improves the Intestinal Mucosal Barrier and Alleviates Colitis by Inhibiting the ROS/TXNIP/TRX/NLRP3 and TLR4/MyD88/NF-κB/NLRP3 Pathways. Inflammation. 48(5). 3529–3541. 5 indexed citations
3.
Lin, Hui, Xian Shao, Jiedong Zhou, et al.. (2025). Indole‐3‐Lactic Acid Inhibits Doxorubicin‐Induced Ferroptosis Through Activating Aryl Hydrocarbon Receptor/Nrf2 Signalling Pathway. Journal of Cellular and Molecular Medicine. 29(2). e70358–e70358. 6 indexed citations
4.
Lin, Hui, Xian Shao, Xiaohong Yu, et al.. (2025). Akkermansia muciniphila ameliorates doxorubicin-induced cardiotoxicity by regulating PPARα-dependent mitochondrial biogenesis. npj Biofilms and Microbiomes. 11(1). 86–86.
5.
Sun, Jing, et al.. (2025). The Effects and Mechanisms of Indole Derivatives in Improving Doxorubicin-Induced Cardiomyopathy. Pharmacology. 110(5). 309–320. 1 indexed citations
6.
Yan, Ling, Haowei Wu, Peipei Zhang, et al.. (2024). Swimming training attenuates doxorubicin induced cardiomyopathy by targeting the mir-17-3p/KEAP1/NRF2 axis. Biochemical and Biophysical Research Communications. 739. 150568–150568. 5 indexed citations
7.
Wu, Haowei, Peipei Zhang, Jiedong Zhou, et al.. (2024). Paeoniflorin confers ferroptosis resistance by regulating the gut microbiota and its metabolites in diabetic cardiomyopathy. American Journal of Physiology-Cell Physiology. 326(3). C724–C741. 17 indexed citations
8.
Yang, Juntao, Jiedong Zhou, Jinjin Hao, et al.. (2024). Blood lipid levels mediating the effects of sex hormone-binding globulin on coronary heart disease: Mendelian randomization and mediation analysis. Scientific Reports. 14(1). 11993–11993. 1 indexed citations
9.
10.
Yang, Juntao, Jiedong Zhou, Jie Yang, et al.. (2024). Dark chocolate intake and cardiovascular diseases: a Mendelian randomization study. Scientific Reports. 14(1). 968–968. 6 indexed citations
11.
Zhou, Jiedong, Jinjin Hao, Juntao Yang, et al.. (2023). Fecal Microbiota Transplantation in Mice Exerts a Protective Effect Against Doxorubicin-Induced Cardiac Toxicity by Regulating Nrf2-Mediated Cardiac Mitochondrial Fission and Fusion. Antioxidants and Redox Signaling. 41(1-3). 1–23. 16 indexed citations
12.
Feng, Qiang, Ying Li, Jiedong Zhou, et al.. (2023). A Versatile PDA(DOX) Nanoplatform for Chemo-Photothermal Synergistic Therapy against Breast Cancer and Attenuated Doxorubicin-Induced Cardiotoxicity. Journal of Nanobiotechnology. 21(1). 338–338. 24 indexed citations
13.
Yang, Juntao, Tingting Lv, Jiedong Zhou, et al.. (2023). The effect of ivabradine therapy on dilated cardiomyopathy patients with congestive heart failure: a systematic review and meta-analysis. Frontiers in Cardiovascular Medicine. 10. 1149351–1149351. 1 indexed citations
14.
Zhang, Hanlin, Jiedong Zhou, Qi Yang, et al.. (2022). Ononin alleviates endoplasmic reticulum stress in doxorubicin-induced cardiotoxicity by activating SIRT3. Toxicology and Applied Pharmacology. 452. 116179–116179. 30 indexed citations
15.
Zhou, Jiedong, Xingxiao Huang, Qi Yang, et al.. (2022). Repair effect of the poly (D,L-lactic acid) nanoparticle containing tauroursodeoxycholic acid-eluting stents on endothelial injury after stent implantation. Frontiers in Cardiovascular Medicine. 9. 1025558–1025558. 2 indexed citations
16.
Wang, Jinquan, Jiedong Zhou, Atsushi Fukunaga, et al.. (2022). Thioredoxin-1: A Promising Target for the Treatment of Allergic Diseases. Frontiers in Immunology. 13. 883116–883116. 18 indexed citations
17.
Lv, Tingting, Junwei Yan, Yunwei Lou, et al.. (2022). Evaluation of Melatonin Therapy in Patients with Myocardial Ischemia‐Reperfusion Injury: A Systematic Review and Meta‐Analysis. Oxidative Medicine and Cellular Longevity. 2022(1). 4610522–4610522. 11 indexed citations
18.
Zhou, Jiedong, et al.. (2022). Functional components of Chinese rice wine can ameliorate diabetic cardiomyopathy through the modulation of autophagy, apoptosis, gut microbiota, and metabolites. Frontiers in Cardiovascular Medicine. 9. 940663–940663. 11 indexed citations
19.
Zhou, Jiedong, et al.. (2022). Prospect of thioredoxin as a possibly effective tool to combat OSAHS. Sleep And Breathing. 27(2). 421–429. 1 indexed citations
20.
Zhou, Jiedong, Jialin Wu, Atsushi Fukunaga, et al.. (2019). Anti-Allergic and Anti-Inflammatory Effects and Molecular Mechanisms of Thioredoxin on Respiratory System Diseases. Antioxidants and Redox Signaling. 32(11). 785–801. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026